Protect the revenue you've
already earned
This isn't cost-cutting. It's recovering the revenue that quietly leaks to authorization delays and preventable denials — with measurable ROI inside 30 days.
Average leaked revenue per DME
When you stop preventable denials before they leave intake, that cash falls straight to the bottom line — typically recovering its own cost within the first 30 days.
What this looks like before DocuFindr.
The average DME supplier loses roughly $180K a year to authorization delays and preventable denials. Without a validation layer, growth just scales the leakage.
Unpredictable Cash Flow
Rejections and rework sit between you and earned revenue, making monthly cash flows erratic and hard to forecast.
Growth Erodes Margin
When you have to add headcount just to handle the administrative burden of growth, it eats into the profit margins you're trying to build.
Burned on Software
You've been sold implementations that promised ROI and didn't land, leaving you paying for tools that your team doesn't actually adopt.
How the validation layer shows up for you.
We don't sell a dashboard. We sell a validation layer with numeric targets that impact your bottom line directly.
Revenue protected at intake.
Stopping denials before submission recovers claims you'd otherwise write off — money you already earned.
ROI in 30 days.
Most suppliers see a measurable impact on their numbers within the first month, not the first year.
Predictable cash flow.
Fewer rejections and faster turnaround smooth the revenue you can count on each month.
Margin-friendly growth.
Absorb more volume on the team you have, so growth widens margin instead of eating it.